| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Terns Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 4,676 | 01 Jul 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TERN | Terns Pharmaceuticals, Inc. | 01 Jul 2024 | 1 | $0 | 4 | Director | 02 Jul 2024, 18:37 |
| TERN | Terns Pharmaceuticals, Inc. | 10 Jun 2024 | 1 | $0 | 4 | Director | 14 Jun 2024, 18:05 |
| TERN | Terns Pharmaceuticals, Inc. | 12 Jun 2023 | 1 | $0 | 4 | Director | 14 Jun 2023, 19:02 |
| TERN | Terns Pharmaceuticals, Inc. | 16 Jun 2022 | 1 | $0 | 4 | Director | 21 Jun 2022, 21:00 |
| TERN | Terns Pharmaceuticals, Inc. | 28 Sep 2021 | 1 | $0 | 4 | Director | 12 Oct 2021, 21:20 |
| TERN | Terns Pharmaceuticals, Inc. | 28 Sep 2021 | 0 | $0 | 3 | Director | 12 Oct 2021, 21:18 |